ACADIA Pharmaceuticals In... (ACAD)
NASDAQ: ACAD
· Real-Time Price · USD
25.18
0.65 (2.65%)
At close: Aug 15, 2025, 1:20 PM
ACADIA Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.02B | 996.28M | 957.8M | 929.24M | 890.53M | 813.81M | 726.44M | 631.89M | 550.9M | 520.23M | 517.24M | 511.5M | 512.4M | 493.06M | 484.14M | 474.39M | 463.36M | 458.24M |
Cost of Revenue | 81.79M | 79.28M | 81.84M | 77.93M | 73.69M | 62.92M | 41.64M | 26.16M | 13.68M | 8.88M | 10.17M | 10.31M | 14.86M | 17.4M | 19.14M | 21.88M | 20M | 20.27M |
Gross Profit | 937.1M | 917M | 875.96M | 851.31M | 816.84M | 750.88M | 684.8M | 605.73M | 537.23M | 511.35M | 507.07M | 501.19M | 497.54M | 475.66M | 465M | 452.51M | 443.36M | 437.97M |
Operating Income | 236.81M | 234.87M | 230.79M | 112.23M | 22.82M | -4.58M | -73.38M | -154.39M | -127.48M | -164.16M | -223.6M | -222.19M | -206.63M | -216.68M | -170.44M | -192.94M | -263.54M | -263.84M |
Interest Income | 20.84M | 19.95M | 25.46M | 23.21M | 20.75M | 18.94M | 17.23M | 16.11M | 14.28M | 10.3M | 6.61M | 3.11M | 943K | 496K | 591K | 1.02M | 2.13M | 3.82M |
Pretax Income | 267.88M | 264.85M | 258.07M | 136.69M | 45.74M | 14.9M | -51.04M | -131.63M | -105.9M | -145.81M | -213.44M | -215.46M | -203.83M | -213.66M | -167.52M | -190.96M | -261.03M | -259.38M |
Net Income | 222.16M | 228.88M | 226.45M | 128.51M | 30.57M | -1.71M | -61.29M | -148.81M | -110.81M | -145.94M | -215.97M | -217.34M | -204.62M | -214.48M | -167.87M | -191.54M | -261.74M | -260.01M |
Selling & General & Admin | 523.25M | 506.81M | 488.43M | 469.81M | 434.41M | 413.31M | 406.56M | 399.5M | 379.71M | 373.65M | 369.09M | 370.46M | 374.02M | 380.9M | 395.89M | 410.87M | 410.79M | 398.35M |
Research & Development | 323.55M | 321.83M | 303.25M | 269.26M | 359.62M | 342.15M | 351.62M | 360.62M | 284.99M | 301.86M | 361.57M | 352.92M | 330.15M | 311.44M | 239.56M | 234.59M | 296.11M | 303.47M |
Other Expenses | -146.51M | -146.13M | -145.84M | 672K | 2.18M | 550K | 264K | 1.81M | 299K | 1.05M | 1.39M | 1.47M | 1.85M | 2.52M | 2.33M | 971K | 386K | 645K |
Operating Expenses | 700.29M | 682.13M | 645.16M | 739.07M | 794.02M | 755.47M | 758.18M | 760.11M | 664.7M | 675.51M | 730.66M | 723.38M | 704.17M | 692.34M | 635.44M | 645.46M | 706.9M | 701.82M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 9.4M | 9.4M | 9.4M | 9.4M | 5.5M | 5.5M | 5.5M | 5.5M | 8.98M | 8.98M | 8.98M | 8.98M | 51.1M | 51.1M | 51.1M |
Cost & Expenses | 782.08M | 761.41M | 727M | 817M | 867.72M | 818.39M | 799.82M | 786.27M | 678.38M | 684.39M | 740.83M | 733.69M | 719.03M | 709.74M | 654.58M | 667.34M | 726.9M | 722.08M |
Income Tax Expense | 45.72M | 35.97M | 31.62M | 8.19M | 15.18M | 16.61M | 10.25M | 17.18M | 4.91M | 128K | 2.53M | 1.89M | 785K | 815K | 351K | 579K | 712K | 632K |
Shares Outstanding (Basic) | 167.83M | 166.81M | 166.53M | 165.97M | 165.55M | 164.8M | 164.81M | 164.23M | 163.46M | 162.26M | 161.99M | 161.85M | 161.65M | 161.23M | 160.87M | 160.66M | 160.42M | 160.01M |
Shares Outstanding (Diluted) | 168.68M | 167.67M | 166.36M | 166.18M | 166.17M | 166.62M | 166.51M | 164.23M | 165.05M | 162.26M | 161.99M | 161.85M | 161.65M | 161.23M | 160.87M | 160.66M | 160.42M | 160.01M |
EPS (Basic) | 1.34 | 1.38 | 1.37 | 0.78 | 0.18 | -0.01 | -0.38 | -0.92 | -0.69 | -0.91 | -1.34 | -1.35 | -1.27 | -1.33 | -1.05 | -1.2 | -1.65 | -1.65 |
EPS (Diluted) | 1.33 | 1.37 | 1.36 | 0.78 | 0.18 | -0.01 | -0.38 | -0.92 | -0.69 | -0.91 | -1.34 | -1.35 | -1.27 | -1.33 | -1.05 | -1.2 | -1.65 | -1.65 |
EBITDA | 106.3M | 99.09M | 97.59M | 121.97M | 34.27M | 6.07M | -67.83M | -149.98M | -124.29M | -162.23M | -221.57M | -220.12M | -204.07M | -213.72M | -167.09M | -188.48M | -259.35M | -259.86M |
EBIT | 98.13M | 95.1M | 96.82M | 129.53M | 40.11M | 9.27M | -65.31M | -151.08M | -124.17M | -164.16M | -223.6M | -222.19M | -206.63M | -216.68M | -170.44M | -192.94M | -263.54M | -263.84M |
Depreciation & Amortization | 8.16M | 10.74M | 13.31M | 9.74M | 11.49M | 10.69M | 5.59M | 4.44M | 3.19M | 1.94M | 2.03M | 2.07M | 2.55M | 2.96M | 3.34M | 3.65M | 3.37M | 3.16M |